Delivery Order SPE2DB20D3104-SPE2DB25FV9Y0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,376.58 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count packaging) on August 4, 2025, with completion targeted for August 5, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count) valued at $2,963.94 with a firm fixed price structure. This delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by August 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count package) under a firm fixed-price contract valued at $1,722.16. This is a non-set-aside competitive award with an ultimate completion date of August 4, 2025, with performance to take place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Dapagliflozin 10 mg tablets in a 30-count package, valued at $1,036.29. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,070.46 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count packages) with an ultimate completion date of August 15, 2025. This competitively awarded contract, issued on August 14, 2025, utilizes a firm fixed price structure with no set-aside designation. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a contract ceiling value of $10,763.89. This firm fixed-price delivery order, which reaches ultimate completion on August 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dapagliflozin 5 mg tablets (30-count) on August 28, 2025, with a ceiling value of $1,296.48 and an ultimate completion date of August 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $9,849.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dapagliflozin 5 mg tablets in quantities of 30 units. This competitively awarded contract, with an ultimate completion date of July 29, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a single delivery order under a larger contract vehicle. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Dapagliflozin 10 mg tablets in a 30-count package at a ceiling value of $1,333.77. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 with a ceiling value of $10,996.65. This is a firm fixed price delivery order with no set-aside designation, completed competitively through open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 28, 2025. This delivery...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FV9Y0Delivery Order
The Defense Logistics Agency awarded a $1,329.27 delivery order to AmerisourceBergen Drug Corp for Dapagliflozin 10 mg tablets (30-count packaging) with an ultimate completion date of September 3, 2025. This is a firm fixed price, non-set-aside contract awarded on September 2, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supply chain support to federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and military personnel. This particular order for Dapagliflozin, a diabetes medication, exemplifies the company's extensive portfolio of pharmaceutical products delivered through competitive federal procurement. The company's federal contracting demonstrates its capability to fulfill diverse medical commodity requirements ranging from brand-name and generic medications to specialized healthcare supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/2/25 |